Agranulocytosis Induced by Ethambutol in a Patient with Pulmonary Tuberculosis |
Moon, Kyoung Min
(Division of Pulmonology, Department of Internal Medicine, Eulji University School of Medicine)
Han, Min Soo (Division of Pulmonology, Department of Internal Medicine, Eulji University School of Medicine) Chung, So Hee (Division of Pulmonology, Department of Internal Medicine, Eulji University School of Medicine) Kim, Ju Ri (Division of Pulmonology, Department of Internal Medicine, Eulji University School of Medicine) Kim, Jin Young (Division of Pulmonology, Department of Internal Medicine, Eulji University School of Medicine) Jung, Sun Young (Division of Pulmonology, Department of Internal Medicine, Eulji University School of Medicine) Cho, Yongseon (Division of Pulmonology, Department of Internal Medicine, Eulji University School of Medicine) |
1 | Umeki S. Adverse effects of antitubercular drugs and significance of measurement of the drug-stimulating lymphocyte transformation rate. Jpn J Med 1989;28:335-40. DOI |
2 | Shishido Y, Nagayama N, Masuda K, Baba M, Tamura A, Nagai H, et al. Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP): a report of four cases and review of the literature. Kekkaku 2003;78:683-9. |
3 | Citron KM. Ethambutol: a review with special reference to ocular toxicity. Tubercle 1969;50:Suppl:32-6. |
4 | Girling DJ. Adverse effects of antituberculosis drugs. Drugs 1982;23:56-74. DOI |
5 | Wong CF, Yew WW. Ethambutol-induced neutropenia and eosinophilia. Chest 1994;106:1638-9. |
6 | Tattersall PE. Agranulocytosis and anaemia associated with disseminated tuberculosis. Br Med J 1957;2:1351-2. DOI |
7 | Jenkins PF, Williams TD, Campbell IA. Neutropenia with each standard antituberculosis drug in the same patient. Br Med J 1980;280:1069-70. DOI |